Sectoral Asset Management as of March 31, 2013
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 56 positions in its portfolio as reported in the March 2013 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) | 5.9 | $192M | 3.5M | 54.97 | |
Incyte Corporation (INCY) | 5.6 | $183M | 7.8M | 23.41 | |
Gilead Sciences (GILD) | 5.0 | $164M | 3.3M | 48.94 | |
Biogen Idec (BIIB) | 4.5 | $147M | 761k | 192.62 | |
Mylan | 4.3 | $141M | 4.9M | 28.95 | |
BioMarin Pharmaceutical (BMRN) | 4.1 | $134M | 2.1M | 62.26 | |
Onyx Pharmaceuticals | 4.0 | $132M | 1.5M | 88.86 | |
Edwards Lifesciences (EW) | 3.9 | $127M | 1.5M | 82.16 | |
Actavis | 3.2 | $106M | 1.1M | 92.11 | |
Illumina (ILMN) | 2.9 | $95M | 1.8M | 53.98 | |
Celgene Corporation | 2.9 | $94M | 810k | 115.91 | |
ImmunoGen (IMGN) | 2.8 | $90M | 5.6M | 16.07 | |
Align Tech | 2.7 | $87M | 2.6M | 33.51 | |
Amgen | 2.6 | $86M | 834k | 102.51 | |
Perrigo Company | 2.6 | $84M | 710k | 118.74 | |
Boston Scientific Corporation (BSX) | 2.5 | $82M | 11M | 7.81 | |
Medivation | 2.5 | $81M | 1.7M | 46.76 | |
Eli Lilly & Co. (LLY) | 2.3 | $76M | 1.3M | 56.79 | |
Ariad Pharmaceuticals | 2.3 | $74M | 4.1M | 18.08 | |
United Therapeutics Corporation (UTHR) | 2.2 | $72M | 1.2M | 60.87 | |
Varian Medical Systems | 2.2 | $72M | 993k | 72.00 | |
Ironwood Pharmaceuticals (IRWD) | 2.1 | $68M | 3.7M | 18.28 | |
Merck & Co (MRK) | 2.0 | $64M | 1.4M | 44.23 | |
Theravance | 1.9 | $63M | 2.6M | 23.62 | |
Hologic (HOLX) | 1.8 | $60M | 2.6M | 22.60 | |
HeartWare International | 1.6 | $53M | 597k | 88.41 | |
Life Technologies | 1.5 | $47M | 733k | 64.63 | |
Valeant Pharmaceuticals Int | 1.4 | $46M | 617k | 75.02 | |
D Alexion Pharmaceutic Als Inc C Common Stock 0 | 1.4 | $45M | 486k | 92.14 | |
InterMune | 1.3 | $43M | 4.8M | 9.05 | |
Regeneron Pharmaceuticals (REGN) | 1.2 | $41M | 231k | 176.40 | |
NxStage Medical | 1.2 | $40M | 3.5M | 11.28 | |
Aveo Pharmaceuticals | 1.2 | $38M | 5.2M | 7.35 | |
Covidien | 1.0 | $31M | 459k | 67.84 | |
Pharmacyclics | 0.9 | $30M | 372k | 80.41 | |
Dex (DXCM) | 0.8 | $27M | 1.6M | 16.72 | |
Shire | 0.8 | $26M | 281k | 91.36 | |
Sequenom | 0.8 | $25M | 5.9M | 4.15 | |
NPS Pharmaceuticals | 0.7 | $24M | 2.3M | 10.20 | |
Thoratec Corporation | 0.5 | $18M | 470k | 37.50 | |
Seattle Genetics | 0.5 | $16M | 437k | 35.50 | |
Teva Pharmaceutical Industries (TEVA) | 0.5 | $15M | 383k | 39.68 | |
Dr. Reddy's Laboratories (RDY) | 0.4 | $14M | 441k | 32.35 | |
Amarin Corporation | 0.4 | $13M | 1.8M | 7.41 | |
Given Imaging | 0.3 | $11M | 699k | 16.35 | |
Sagent Pharmaceuticals | 0.3 | $11M | 651k | 17.55 | |
Akorn | 0.3 | $11M | 795k | 13.83 | |
Momenta Pharmaceuticals | 0.3 | $11M | 805k | 13.34 | |
3SBio (SSRX) | 0.3 | $11M | 713k | 15.20 | |
Achillion Pharmaceuticals | 0.3 | $10M | 1.2M | 8.75 | |
Halozyme Therapeutics (HALO) | 0.3 | $9.7M | 1.7M | 5.77 | |
OraSure Technologies (OSUR) | 0.3 | $8.6M | 1.6M | 5.40 | |
Accuray | 0.2 | $5.2M | 1.1M | 4.64 | |
Novo Nordisk A/S (NVO) | 0.1 | $1.8M | 11k | 161.49 | |
Novartis (NVS) | 0.0 | $584k | 8.2k | 71.22 | |
CHINA CORD Blood Corp | 0.0 | $229k | 78k | 2.93 |